Press releases 2007

• 2007/068 NICE consults on proposal for dose-capping scheme to make Lucentis available on the NHS

  13/12/2007

• 2007/067 NICE/NPSA issues its first patient safety solution guidance to improve medicines reconciliation at hospital admission

  12/12/2007

• 2007/066 NICE guideline to improve management and treatment of children with atopic eczema

  12/12/2007

• 2007/065 NICE consults on new appraisal methodologies

  06/12/2007

• 2007/064 New guide will help to change practice

  05/12/2007

• 2007/063 Have your say on the social values that underpin NICE guidance

  30/11/2007

• 2007/061 NICE appraisal of inhaled corticosteroids for the treatment of asthma in children under the age of 12

  28/11/2007

• 2007/060 NICE issues guidance on ezetimibe for primary hypercholesterolaemia

  28/11/2007

• 2007/059 New NICE guidance for schools published to prevent and reduce alcohol use in children and young people

  28/11/2007

• 2007/058 NICE welcomes new non-executive director to its Board

  12/11/2007

• 2007/056 NICE guidance on bortezomib (Velcade) is a win-win solution for multiple myeloma patients and the NHS

  24/10/2007

• 2007/055 NICE appraisal of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis

  24/10/2007

• 2007/054 NICE public health guidance aims to help people change their behaviour so that they can enjoy healthier lives

  24/10/2007

• 2007/053 NICE recommends stapled haemorrhoidopexy for the treatment of prolapsed haemorrhoids

  26/09/2007

• 2007/052 Managing head injury: updated NICE guidelines published

  26/09/2007

• 2007/051 NICE publish guidelines to improve women's experience of labour

  26/09/2007

• 2007/050 NICE consults on its first patient safety solution guidance

  13/09/2007

• 2007/049 NICE complies with judge's ruling on judicial review

  07/09/2007

• 2007/047 NICE issues guidance on pemetrexed (Alimta) for the treatment of non-small-cell lung cancer

  22/08/2007

• 2007/046 NICE recommends natalizumab for the treatment of multiple sclerosis

  22/08/2007

• 2007/045 New NICE guideline to improve diagnosis and management of chronic fatigue syndrome in adults and children

  22/08/2007

• 2007/044 NICE appraisal of rituximab and adalimumab for the treatment of arthritis

  22/08/2007

• 2007/043 New NICE guidelines to improve management of urinary tract infections in children

  22/08/2007

• 2007/042a Updated: NICE responds to judicial review outcome

  10/08/2007

• 2007/042 NICE responds to judicial review outcome

  10/08/2007

• 2007/039 NICE approves varenicline for smoking cessation

  25/07/2007

• 2007/038 NICE guidelines published to improve treatment for substance misuse

  25/07/2007

• 2007/036 NICE welcomes referral of new topics

  06/07/2007

• 2007/035 NICE issues guidance on the use of “clot-busters” in the treatment of strokes

  27/06/2007

• 2007/034 NICE issues guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

  26/06/2007

• 2007/033 New NICE guidance published to help manage distressing bowel problem

  27/06/2007

• 2007/032 NICE Chairman welcomes CBE for Professor David Barnett, Chair of Appraisal Committee

  16/06/2007

• 2007/031 NICE issues draft guidance on drugs for the treatment of age related macular degeneration

  14/06/2007

• 2007/030 NICE Citizens Council to discuss patient safety

  05/06/2007

• 2007/028 NICE appraisal on varenicline (Champix) for smoking cessation

  30/05/2007

• 2007/027 NICE guidance set to increase the number of patients receiving life-saving cardiac resynchronisation therapy to treat heart failure

  23/05/2007

• 2007/026 New NICE guidelines are set to reduce premature deaths in people who have had a heart attack

  23/05/2007

• 2007/025 NICE issues guidance to help assess children with fever

  21/05/2007

• 2007/024 NICE and the NPSA launch pilot to investigate new safety solutions for the NHS

  14/05/2007

• 2007/023 NICE comes to Nottinghamshire

  14/05/2007

• 2007/022 NICE amends depression and anxiety guidance in line with safety recommendations

  25/04/2007

• 2007/021 NICE guideline to reduce life-threatening blood clots in surgical patients

  25/04/2007

• 2007/020 Give quit smoking help at work, says NICE

  25/04/2007

• 2007/018 NICE recommends a scheme to make bortezomib (Velcade) for multiple myeloma accessible to NHS patients

  04/06/2007

• 2007/017 New NICE guidance calls for early intervention to support vulnerable young people at risk of substance misuse

  28/03/2007

• 2007/016 NICE help for employers ahead of smoking ban

  23/03/2007

• 2007/015 NICE launches second consultation on draft recommendations relating to birth settings

  22/03/2007

• 2007/013 NICE guidance calls for more to be done to halt the rise of sexually transmitted infections and prevent under 18 conceptions

  28/02/2007

• 2007/012 NICE publishes guidance on fludarabine for chronic lymphocytic leukaemia

  28/02/2007

• 2007/011 NICE issues guidance to help detect and treat women with antenatal and postnatal mental health disorders

  28/02/2007

• 2007/010 New chair and vice-chair join the Research and Development Advisory Committee

  23/02/2007

• 2007/009 NICE asked to develop guidance on new treatments for breast and lung cancer, Crohn´s disease, ulcerative colitis, obesity and rheumatoid arthritis

  07/02/2007

• 2007/008 New non-executive directors join the NICE board

  31/01/2007

• 2007/007 NICE issues guidance for the management of opioid dependence

  25/01/2007

• 2007/006 NICE publishes final guidance on bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

  24/01/2007

• 2007/005 NICE issues guidance on treating secondary hyperparathyroidism in patients with kidney disease

  24/01/2007

• 2007/004 NICE guidance highlights new treatment options available to women living with heavy menstrual bleeding

  24/01/2007

• 2007/003 NICE Citizens Council to discuss ´only in research´ recommendations

  22/01/2007

• 2007/002 NICE comes to Sunderland

  08/01/2007

• 2007/001 NICE response to judicial review proceedings

  05/01/2007